ATE450253T1 - Pharmazeutische flüssige suspensionen - Google Patents
Pharmazeutische flüssige suspensionenInfo
- Publication number
- ATE450253T1 ATE450253T1 AT04013422T AT04013422T ATE450253T1 AT E450253 T1 ATE450253 T1 AT E450253T1 AT 04013422 T AT04013422 T AT 04013422T AT 04013422 T AT04013422 T AT 04013422T AT E450253 T1 ATE450253 T1 AT E450253T1
- Authority
- AT
- Austria
- Prior art keywords
- liquid suspensions
- pharmaceutical liquid
- particles
- liquid
- pharmaceutical
- Prior art date
Links
- 239000006194 liquid suspension Substances 0.000 title 1
- 239000007788 liquid Substances 0.000 abstract 3
- 239000002245 particle Substances 0.000 abstract 3
- 239000004615 ingredient Substances 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 238000005057 refrigeration Methods 0.000 abstract 1
- 230000000087 stabilizing effect Effects 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 239000000725 suspension Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6921—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
- A61K47/6923—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being an inorganic particle, e.g. ceramic particles, silica particles, ferrite or synsorb
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Ceramic Engineering (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP00973483A EP1328255A1 (de) | 2000-10-13 | 2000-10-13 | Zusammenstzung und verfahren für injizierbare flüssigkeiten |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE450253T1 true ATE450253T1 (de) | 2009-12-15 |
Family
ID=41401562
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04013422T ATE450253T1 (de) | 2000-10-13 | 2000-10-13 | Pharmazeutische flüssige suspensionen |
Country Status (4)
| Country | Link |
|---|---|
| EP (2) | EP1452171B1 (de) |
| AT (1) | ATE450253T1 (de) |
| DE (1) | DE60043459D1 (de) |
| DK (1) | DK1452171T3 (de) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2498774A (en) * | 2012-01-27 | 2013-07-31 | Bruce Roser | Glass-stabilised biological materials and syringe |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GR78151B (de) * | 1982-04-05 | 1984-09-26 | Alcon Lab Inc | |
| EP0229810B1 (de) * | 1985-07-09 | 1991-10-16 | Quadrant Bioresources Limited | Beschützung von proteinen und ähnlichem |
| GB9010742D0 (en) * | 1990-05-14 | 1990-07-04 | Quadrant Bioresources Ltd | Stabilization of biological macromolecular substances |
| US5496535A (en) * | 1991-04-12 | 1996-03-05 | Alliance Pharmaceutical Corp. | Fluorocarbon contrast media for use with MRI and radiographic imaging |
| WO1993018748A1 (en) * | 1992-03-19 | 1993-09-30 | Allergan, Inc. | Compositions comprising a drug delivery vehicle suspended in a nonaqueous fluorinated liquid |
| US5589167A (en) * | 1993-02-23 | 1996-12-31 | Genentech, Inc. | Excipient stabilization of polypeptides treated with organic solvents |
| CA2197982C (en) * | 1994-08-04 | 2010-03-23 | Bruce Joseph Roser | Solid delivery systems for controlled release of molecules incorporated therein and methods of making same |
| GB9705588D0 (en) * | 1997-03-18 | 1997-05-07 | Anglia Research Foundation | Stable particle in liquid formulations |
| EP1071465A1 (de) * | 1998-03-18 | 2001-01-31 | Ronai, Peter | Amorphe gläser zur stabilisierung von empfindlichen produkten |
| US6190701B1 (en) * | 1999-03-17 | 2001-02-20 | Peter M. Ronai | Composition and method for stable injectable liquids |
-
2000
- 2000-10-13 DE DE60043459T patent/DE60043459D1/de not_active Expired - Lifetime
- 2000-10-13 EP EP04013422A patent/EP1452171B1/de not_active Expired - Lifetime
- 2000-10-13 AT AT04013422T patent/ATE450253T1/de not_active IP Right Cessation
- 2000-10-13 DK DK04013422.3T patent/DK1452171T3/da active
- 2000-10-13 EP EP04010391A patent/EP1449523A1/de not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| DE60043459D1 (de) | 2010-01-14 |
| EP1452171A3 (de) | 2004-11-10 |
| DK1452171T3 (da) | 2010-04-06 |
| EP1452171A2 (de) | 2004-09-01 |
| EP1449523A1 (de) | 2004-08-25 |
| EP1452171B1 (de) | 2009-12-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2004058156A3 (en) | High pressure spray-dry of bioactive materials | |
| DE60219006D1 (de) | Modifizierte und stabilizierte gdf propeptide und ihre verwendungen | |
| DE60234945D1 (de) | Pulver zur nasalen verabreichung von wirkstoffen | |
| ATE395042T1 (de) | Darreichungsformen welche mikropartikel und treibgas enthalten | |
| ID26033A (id) | Metode penstabilan komposisi bahan farmasi dengan penggunaan khusus dari antioksidan | |
| ECSP045154A (es) | Composiciones de fórmula para infantes que comrende cantidades aumentadas de alfa - lactalbumin | |
| BR0206551B1 (pt) | bolsa plástica de múltiplas pregas descartável e sistema para melhorar a descarga de um material bombeável de uma bolsa plástica. | |
| ATE507822T1 (de) | Stabilisierte zusammensetzungen von faktor-vii- polypeptiden | |
| ATE345277T1 (de) | Injizierbare pharmazeutische suspension in einer phiole mit zwei kammern | |
| EP1480598A4 (de) | Manipulation von zytokin-konzentrationen mit cd83 genprodukten | |
| ATE433961T1 (de) | Ansamycine mit verbesserten pharmakologischen und biologischen eigenschaften | |
| NO20056020L (no) | Smapartiklet farmasoytisk formulering av midler mot anfall og demens, og immunsuppresjonsmidler | |
| NO991942L (no) | FremgangsmÕte for fremstilling av malonat metyliden nanopartikler, nanopartikler eventuelt inneholdende ett eller flere biologisk aktive molekyler | |
| EA200400148A1 (ru) | Стабилизированная суспензионная лекарственная форма для перорального применения | |
| ITMI20021476A0 (it) | Macchina vibrante particolarmente studiata per l'estrazione la miscelazione e la separazione di materie organiche ed inorganiche sia liquide | |
| ATE411802T1 (de) | Kombinationspräparate von 1,4- benzothiepin-1,1- dioxidderivaten mit weiteren wirkstoffen und deren verwendung | |
| TWI255737B (en) | A straw for the conservation of small quantities of substances, in particular biological liquids | |
| BR0008661A (pt) | Absorventes para uso no manuseio de fluidoscomplexos | |
| DE60043459D1 (de) | Pharmazeutische flüssige Suspensionen | |
| BR0110605A (pt) | Recipiente suspenso para essências com meios para sua absorção e difusão do seu perfume para o meio ambiente | |
| DE60133050D1 (de) | Verwendung von substanzen mit oxytocin aktivität gegen klimakterische beschwerden | |
| DE50106179D1 (de) | Carotinoidtrockenpulver mit einer Multi-Kern Struktur | |
| ATE489941T1 (de) | Nicht-lamellare zubereitungen von dioleoyl- phosphatidyl ethanolamin und polysorbat80 | |
| ATE355828T1 (de) | Partikuläre zusammensetzung enthaltend eine lipophile flüssigkeit | |
| BG104133A (bg) | Метод за получаване на невирапин хемихидрат и фармацевтичен състав, който го съдържа |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |